Received Dec 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | M4B34 | — |
Twinrix adult dose to a 10-year-old patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug administered to patient of inappropriate age in a 10-year-old male patient who received HAB (Twinrix) (batch number M4B34, expiry date 28-SEP-2026) for prophylaxis. On 13-OCT-2025, the patient received Twinrix. On 13-OCT-2025, an unknown time after receiving Twinrix, the patient experienced drug administered to patient of inappropriate age (Verbatim: Twinrix adult dose to a 10-year-old patient). The outcome of the drug administered to patient of inappropriate age was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 08-DEC-2025